Table 1.: Drugs Associated to the Development of Interstitial Lung Disease

Antimicrobial Agents
●   Amphotericin B
●   Isoniazid
●   Nitrofurantoin
●   Sulfasalazine
Anti-Inflammatory Agents
●   Aspirin
●   Etanercept
●   Gold
●   Infliximab
●   Methotrexate
●   Nonsteroidal anti-inflammatory drugs
●   Penicillamine
Biological Agents
●   Adalimumab
●   Alemtuzumab
●   Bevacizumab
●   Cetuximab
●   Rituximab
●   Trastuzumab
●   Tumor necrosis factor (TNF)-α blockers
Cardiovascular Agents
●   ACE inhibitors
●   Amiodarone
●   Anticoagulants
●   ß-Blockers
●   Flecainide
●   Hydrochlorothiazide
●   Procainamide
●   Statins
●   Tocainide
Chemotherapeutic Agents
●   Azathioprine
●   BCNU
Chemotherapeutic Agents
●   Bleomycin
●   Bortezomib
●   Busulfan
●   Carmustine
●   Chlorambucil
●   Colony-stimulating factors
●   Cyclophosphamide
●   Cytarabine
●   Deferoxamine
●   Docetaxel
●   Doxorubicin
●   Erlotinib
●   Etoposide
●   Fludarabine
●   Flutamide
●   Gefitinib
●   Gemcitabine
●   Hydroxyurea
●   Imatinib
●   Interferons
●   Lomustine
●   Melphalan
●   Methotrexate
●   Methyl-CCNU
●   Mitomycin-C
●   Nitrosoureas
●   Paclitaxel
●   Procarbazine
●   Thalidomide
●   Vinblastine
●   Zinostatin
Miscellanous
●   Bromocriptine
●   Carbamazepine
●   Cabergolide
●   Methysergide
●   Penicillamine
●   Phenytoin
●   Sirolimus
●   Talc